Six months immunity following COVID-19 infection, say researchers
Immunity can last for up to six months following a COVID-19 infection, a new study has shown.
As part of a collaboration between the University...
Global leaders advocate urgent action on antimicrobial resistance
As the antimicrobial resistance crisis accelerates across the globe, world leaders are advocating for urgent action to combat the problem.
The leaders, including the heads...
European Commission steps up rapid COVID-19 testing
The European Commission will be stepping up rapid COVID-19 antigen testing and support to increase testing capacity.
The move follows the European Commission's recommendation to...
Groundbreaking cannabis education for UK healthcare professionals
The Cannabis Patient Advocacy & Support Services (CPASS) is launching a new groundbreaking, Multi-Disciplinary Team (MDT) webinar series on medical cannabis for healthcare professionals...
Over 50s in UK to receive free flu vaccine
The UK Government has announced that citizens over 50 in the UK will be able to receive a free flu vaccine from 1 December...
EU court rules CBD is ‘not a narcotic’
In a landmark move the Court of Justice of the European Union (CJEU) has ruled the cannabinoid CBD is ‘not a narcotic’, as it...
Sleep disorder drug modafinil linked to increased risk of birth defects
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to people using the sleep disorder drug modafinil while pregnant, due to an association with increased risk of birth defects.
Tommy Chong: “We’re going back to the future with cannabis.”
Cannabis activist, musician, and comedy actor Tommy Chong gives his thoughts on the emergence of America’s legal cannabis industry.
Chong is an icon of cannabis...
Oxford COVID-19 vaccine shows promising results in older adults
Phase II of the Oxford vaccine trial has shown promising safety results in older adults, finding it provokes an immune response.
The early stage results,...
Autistic children risk delays to diagnosis due to COVID-19 lockdowns
New research has shown that more than 128,000 children and their families risk being ‘forgotten’ by the system as lockdown causes delays in autism...
Care homes to be tested for COVID-19 immune response
Thousands of care home staff and residents in the UK are to have their immune response to COVID-19 tested as part of an expansion...
COVID-19 care home deaths in UK ‘hugely underestimated’
An early draft of a recent study has shown that up to 10,000 more people may have died in care homes from COVID-19 than...
Non-hereditary mutation acts as natural gene therapy for GATA2 deficiency
Scientists have identified a non-inherited mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other...
Mental health, COVID-19 and the workplace
The UK’s Health and Safety Executive speaks to HEQ about COVID-19 and mental health at work.
With the COVID-19 pandemic still nowhere close to a...
Lung cancers detected early as a result of pioneering trial
A lung cancer trial, aiming to detect disease in higher risk patients before they show symptoms, has caught dozens of cases early.
Hospitals in England to receive funding for digital prescribing
The UK Government is providing £16m in funding to hospitals across England to introduce digital prescribing.
Patients and staff across 16 hospitals in England are...
Modified CBD molecules could help in the fight against skin disease
Researchers have modified the cannabidiol compound (CBD) found in cannabis to try to improve the properties that fight against skin disease.
A partnership between the...
Megalabs to transform diagnostics facilities in the UK
Yesterday the UK Government announced the opening of two new megalabs which will add 300,000 to the UK’s daily testing capacity.
As part of the...
COVID-19 and infection control in Europe
ECDC experts Dr Agoritsa Baka and Dr Diamantis Plachouras tell HEQ about public health planning infection control policy during the COVID-19 pandemic.
The European Centre...
European Commission approves epilepsy medicine to treat children
The European Commission has approved expanding the indication of anti-epileptic agent Fycompa to include the treatment of children with epilepsy.
The European Commission (EC) has...